Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

Home > Science Hub > Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials
Back to the list

April 7, 2025

Matt Clutter

You might also be interested by

CellTalk Blog

Next-Gen Immune Monitoring: The Value of Single-Cell Sequencing

August 12, 2025

More info

Web News

CellCarta and Tivenix Strategic Partnership

July 21, 2025

More info

Web News

CellCarta Appoints Elliott Miller as Chief Financial Officer

July 7, 2025

More info

Posters

High Quality Whole Transcriptome RNA-Sequencing from Challenging Clinical Samples

June 23, 2025

More info